Nanotechnology in Retinal Disease: Current Concepts and Future Directions

Area of Science:

• Ophthalmology and Nanomedicine
• Biotechnology and Materials Science

Background:

• Retinal diseases cause significant global blindness, impacting millions and leading to substantial productivity loss.
• Age-related macular degeneration and inherited retinal diseases (IRDs) are major causes of vision impairment, with IRDs affecting over 2 million people worldwide.
• Current treatments face challenges in efficacy and targeted delivery within the complex retinal environment.

Purpose of the Study:

• To review current and emerging nanotechnological applications in retinal diagnostics, theranostics, and drug delivery.
• To explore the potential of nanobiotechnology and bionanotechnology in addressing retinal diseases.
• To discuss the role of nanoparticles and advanced diagnostic tools in retinal care and regenerative medicine.

Main Methods:

• Review of current literature on nanobiotechnology and its applications in ophthalmology.
• Analysis of nanoparticle structures, functions, and their use in diagnostic and therapeutic strategies.
• Discussion of nonviral drug delivery vehicles and advanced sensing technologies.

Main Results:

• Nanoparticles like liposomes, micelles, and dendrimers show promise for targeted retinal drug delivery, offering advantages over viral vectors.
• Emerging nanotechnologies are enhancing retinal diagnostics, including next-generation DNA sequencing and single-molecule bionanosensing.
• Nanomaterials are being investigated for surgical adjuncts and regenerative medicine approaches for retinal repair.

Conclusions:

• Nanobiotechnology presents a rapidly advancing frontier for diagnosing and treating a spectrum of retinal diseases.
• Nonviral nanocarriers and advanced diagnostic tools are poised to revolutionize retinal disease management.
• Future applications in regenerative medicine and surgical support highlight the transformative potential of nanotechnology in ophthalmology.